Skip to main content

Table 2 Treatments provided during the 72 h following enrolment and outcomes of the study cohort

From: Haemoglobin concentration and volume of intravenous fluids in septic shock in the ARISE trial

Treatments and outcomes

Cohort (N = 1275)

Treatments

 

Central venous cannula inserted – N (%)

1053 (82.6%)

Arterial cannula inserted – N (%)

1082 (84.9%)

Admitted to ICU – N (%)

1092 (85.6%)

Received surgery – N (%)

117 (9.2%)

Received mechanical ventilationaN (%)

480 (37.6%)

Received an infusion of a vasoactive agentbN (%)

858 (67.3%)

Duration of vasoactive agent infusion – hours (IQR)

29 (12–57)

Outcomes

 Invasive ventilation

  Number that received invasive ventilationcN (%)

352 (27.6%)

  Duration of invasive ventilation – hours (IQR)

61 (22–163)

 Length of stay – days (IQR)

  ICU

2.6 (1.3–5.0)

  Hospital

8.1 (4.9–15.3)

 Mortality – N (%)

  ICU

109 (8.5%)

  Hospital

162 (12.7%)

  Day 28

163 (12.8%)

  Day 90

193 (15.1%)

  1. aMechanical ventilation included invasive and non-invasive modes
  2. bInfusion of vasoactive drugs included noradrenaline, adrenaline, metaraminol, phenylephrine and/or dopamine for at least 30 min
  3. cInvasive mechanical ventilation at any time during hospital admission